A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study will identify the optimum concentrations of AGN-199201 and AGN-190584 when dosed in combination once a day for the improvement of uncorrected near visual acuity in participants with presbyopia (inability to focus on items close-up).
Epistemonikos ID: 87a8c4691ec63237811bad3519224f05241b5541
First added on: May 12, 2024